Fig 1.
Map of participating countries and number of laboratories per country in the 2022 EVD-LabNet EU/EEA External Quality Assessment for molecular detection of alphaviruses.
Table 1.
Alphavirus testing capacity as indicated by participating laboratories in the 2022 EVD-LabNet External Quality Assessment of molecular testing for nine human alphaviruses.
Fig 2.
Overview of final diagnostic conclusions assessed per self-reported capacities in the 2022 EVD-LabNet External Quality Assessment of molecular testing for alphaviruses.
Table 2.
Performance of all assays used in the 2022 EVD-LabNet EQA on molecular detection of alphaviruses. Incorrect results can be either false negative, false positive for a different alpha virus species, false positive for a negative sample or inconclusive.
Table 3.
Composition of panels for molecular detection of alphaviruses, EVD-LabNet EQA, 2022.